Transaction | Address | Amount |
---|---|---|
0x2b95...1ed4a3
|
0x1bd5...22b65b
|
-
0.020218799999999997 WETH
·
72.15 USD
|
0x2b95...1ed4a3
|
0x5141...40a190
|
+
0.020218799999999997 WETH
·
72.15 USD
|
0x2b95...1ed4a3
|
0x5141...40a190
|
-
348.6 TLOS
|
0x2b95...1ed4a3
|
0x1bd5...22b65b
|
+
348.6 TLOS
|
0x61ee...e4185f
|
0xad22...1dccf0
|
-
185 USDT
·
184.98 USD
|
0x61ee...e4185f
|
0x9e65...cf2bbf
|
+
185 USDT
·
184.98 USD
|
180 Life Sciences rebrands as ETHZilla, launching a $425M Ethereum treasury to pivot into blockchain finance, utilizing Ethereum as a core asset.
BitMine opts for a $1 billion share repurchase plan, prioritizing buybacks over increasing its Ethereum holdings, as its stock trades below net asset value.
Abraxas Capital faces $100M in unrealized losses on $800M crypto shorts amidst a bullish market.